Skip to content
Toggle navigation
Sign Up
Contact
Twitter
LinkedIn
Search
Search
About CARB-X
Overview
Global Threat
Our Strategy
Stewardship and Access
Management & Staff
Joint Oversight Board
Advisory Board
Careers
Annual Reports
Boston University School of Law
Portfolio
Portfolio Product Developers
Portfolio-Pipeline
CARB-X Graduates
Spotlight on Science
Portfolio Acceleration Tools
Comprehensive Support
Partners
Funding Partners
Global Accelerator Network
Apply
Funding Themes
Application Process
Entering Portfolio
Apply Here
Omnibus Outcomes
Resources
CARB-X Connect
Presentations
Videos
Publications
Education
PD Resources
Fact Sheets
AMR Test Directory
Research Compliance
News
CARB-X News
Recommended News
In the News
Antibiotic Resistance
Product Developer News
Events
About CARB-X
Overview
Global Threat
Our Strategy
Stewardship and Access
Management & Staff
Joint Oversight Board
Advisory Board
Careers
Annual Reports
Boston University School of Law
Portfolio
Portfolio Product Developers
Portfolio-Pipeline
CARB-X Graduates
Spotlight on Science
Portfolio Acceleration Tools
Comprehensive Support
Partners
Funding Partners
Global Accelerator Network
Apply
Funding Themes
2024 Solicitation
Application Process
Entering Portfolio
Resources
Presentations
Videos
Publications
Education
PD Resources
Fact Sheets
AMR Test Directory
News
CARB-X News
Recommended News
In the News
Antibiotic Resistance
Product Developer News
Events
Contact
Legal
News
Cheshire-based biotech scores £30m Series A round
Cheshire-based biotech scores £30m Series A round
We use cookies to ensure that we give you the best experience on our website. Please visit carb-x.org/legal/ for more information. By clicking “Ok”, you consent to the use of all cookies.
Ok
I do not consent
Toggle navigation